Annual Total Liabilities
$1.04 B
-$159.47 M-13.24%
December 31, 2023
Summary
- As of February 8, 2025, PACB annual total liabilities is $1.04 billion, with the most recent change of -$159.47 million (-13.24%) on December 31, 2023.
- During the last 3 years, PACB annual total liabilities has risen by +$966.22 million (+1231.03%).
- PACB annual total liabilities is now -14.09% below its all-time high of $1.22 billion, reached on December 31, 2021.
Performance
PACB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$996.93 M
-$19.86 M-1.95%
September 30, 2024
Summary
- As of February 8, 2025, PACB quarterly total liabilities is $996.93 million, with the most recent change of -$19.86 million (-1.95%) on September 30, 2024.
- Over the past year, PACB quarterly total liabilities has dropped by -$19.86 million (-1.95%).
- PACB quarterly total liabilities is now -18.01% below its all-time high of $1.22 billion, reached on December 31, 2021.
Performance
PACB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
PACB Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.2% | -1.9% |
| 3 y3 years | +1231.0% | -16.5% |
| 5 y5 years | +1758.5% | +948.3% |
PACB Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.1% | at low | -18.0% | at low |
| 5 y | 5-year | -14.1% | +1231.0% | -18.0% | +1170.2% |
| alltime | all time | -14.1% | +5046.1% | -18.0% | +4968.0% |
Pacific Biosciences Of California Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $996.93 M(-2.0%) |
| Jun 2024 | - | $1.02 B(-0.4%) |
| Mar 2024 | - | $1.02 B(-2.3%) |
| Dec 2023 | $1.04 B(-13.2%) | $1.04 B(-7.9%) |
| Sep 2023 | - | $1.13 B(-5.9%) |
| Jun 2023 | - | $1.21 B(+0.1%) |
| Mar 2023 | - | $1.20 B(+0.0%) |
| Dec 2022 | $1.20 B(-1.0%) | $1.20 B(+1.0%) |
| Sep 2022 | - | $1.19 B(-0.2%) |
| Jun 2022 | - | $1.19 B(-0.7%) |
| Mar 2022 | - | $1.20 B(-1.1%) |
| Dec 2021 | $1.22 B(+1449.2%) | $1.22 B(+1.9%) |
| Sep 2021 | - | $1.19 B(+20.8%) |
| Jun 2021 | - | $987.54 M(+1.6%) |
| Mar 2021 | - | $972.34 M(+1138.8%) |
| Dec 2020 | $78.49 M(-15.7%) | $78.49 M(-54.1%) |
| Sep 2020 | - | $170.82 M(-0.8%) |
| Jun 2020 | - | $172.26 M(-1.2%) |
| Mar 2020 | - | $174.36 M(+87.3%) |
| Dec 2019 | $93.07 M(+65.6%) | $93.07 M(-2.1%) |
| Sep 2019 | - | $95.10 M(+0.3%) |
| Jun 2019 | - | $94.83 M(+4.5%) |
| Mar 2019 | - | $90.73 M(+61.4%) |
| Dec 2018 | $56.21 M(-3.0%) | $56.21 M(+10.2%) |
| Sep 2018 | - | $51.03 M(-1.1%) |
| Jun 2018 | - | $51.58 M(-4.8%) |
| Mar 2018 | - | $54.21 M(-6.5%) |
| Dec 2017 | $57.98 M | $57.98 M(+2.6%) |
| Sep 2017 | - | $56.50 M(-8.9%) |
| Jun 2017 | - | $62.05 M(-6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2017 | - | $66.32 M(+24.6%) |
| Dec 2016 | $53.22 M(-7.6%) | $53.22 M(+2.4%) |
| Sep 2016 | - | $51.95 M(-2.5%) |
| Jun 2016 | - | $53.30 M(+3.7%) |
| Mar 2016 | - | $51.40 M(-10.7%) |
| Dec 2015 | $57.57 M(-17.1%) | $57.57 M(-1.4%) |
| Sep 2015 | - | $58.41 M(-7.2%) |
| Jun 2015 | - | $62.93 M(-4.6%) |
| Mar 2015 | - | $65.95 M(-5.0%) |
| Dec 2014 | $69.44 M(+3.6%) | $69.44 M(+1.2%) |
| Sep 2014 | - | $68.61 M(-0.9%) |
| Jun 2014 | - | $69.23 M(+5.7%) |
| Mar 2014 | - | $65.52 M(-2.2%) |
| Dec 2013 | $67.00 M(+230.1%) | $67.00 M(-3.3%) |
| Sep 2013 | - | $69.26 M(+104.4%) |
| Jun 2013 | - | $33.88 M(+3.7%) |
| Mar 2013 | - | $32.68 M(+61.0%) |
| Dec 2012 | $20.30 M(-24.4%) | $20.30 M(+3.2%) |
| Sep 2012 | - | $19.67 M(-9.5%) |
| Jun 2012 | - | $21.73 M(-19.0%) |
| Mar 2012 | - | $26.84 M(-0.1%) |
| Dec 2011 | $26.85 M(+3.8%) | $26.85 M(-1.6%) |
| Sep 2011 | - | $27.28 M(-2.2%) |
| Jun 2011 | - | $27.89 M(-6.7%) |
| Mar 2011 | - | $29.89 M(+15.5%) |
| Dec 2010 | $25.88 M(-90.7%) | $25.88 M(-93.6%) |
| Sep 2010 | - | $403.24 M(+1799.5%) |
| Jun 2010 | - | $21.23 M(-92.4%) |
| Dec 2009 | $278.22 M(+34.7%) | $278.22 M |
| Dec 2008 | $206.50 M | - |
FAQ
- What is Pacific Biosciences of California annual total liabilities?
- What is the all time high annual total liabilities for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual total liabilities year-on-year change?
- What is Pacific Biosciences of California quarterly total liabilities?
- What is the all time high quarterly total liabilities for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly total liabilities year-on-year change?
What is Pacific Biosciences of California annual total liabilities?
The current annual total liabilities of PACB is $1.04 B
What is the all time high annual total liabilities for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual total liabilities is $1.22 B
What is Pacific Biosciences of California annual total liabilities year-on-year change?
Over the past year, PACB annual total liabilities has changed by -$159.47 M (-13.24%)
What is Pacific Biosciences of California quarterly total liabilities?
The current quarterly total liabilities of PACB is $996.93 M
What is the all time high quarterly total liabilities for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly total liabilities is $1.22 B
What is Pacific Biosciences of California quarterly total liabilities year-on-year change?
Over the past year, PACB quarterly total liabilities has changed by -$19.86 M (-1.95%)